ライフサイエンスコーパス: interval

1 rity was based on a 1-sided 97.5% confidence interval.

2 appetitive trace conditioning at a 2 s trace interval.

3 incidence of unplanned PPV during the study interval.

4 in length effect was fine-mapped to a 4.3 cM interval.

5 tegravir 800 mg or saline placebo at 12 week intervals.

6 eding, and illness were collected at defined intervals.

7 rnating between short and long interstimulus intervals.

8 SUVR) calculated over different imaging time intervals.

9 ant control on survival during nonextinction intervals.

10 s of BCC (hazard ratio = 0.6; 95% confidence interval = 0.4-0.9) but significantly higher risks of SC

11 [0.77, 0.88], vertical 0.76, 95% confidence interval [0.68, 0.82]).

12 coefficient horizontal 0.83, 95% confidence interval [0.77, 0.88], vertical 0.76, 95% confidence int

13 pulation (hazard ratio, 0.57; 95% confidence interval, 0.33-0.98; P=0.04).

14 patients (hazard ratio, 0.54; 95% confidence interval, 0.36-0.82).

15 he POC arm (odds ratio, 1.13; 95% confidence interval, 0.51-2.53; P = 0.76; risk difference, 3.1%; 95

16 d sisters hazard ratios=0.65 (95% confidence interval, 0.52-0.80), respectively.

17 (adjusted hazard ratio, 0.73; 95% confidence interval, 0.58-0.92; P=0.007).

18 brothers hazard ratios=0.69 (95% confidence interval, 0.61-0.78) and sisters hazard ratios=0.65 (95%

19 infarction (odds ratio, 0.76; 95% confidence interval, 0.61-0.94; P=0.01) compared with CAG performed

20 asked hypertension was 0.681 (95% confidence interval, 0.640-0.723) for ASCVD risk and 0.703 (95% con

21 23) for ASCVD risk and 0.703 (95% confidence interval, 0.663-0.744) for clinic systolic BP and diasto

22 CI alone (hazard ratio, 0.84; 95% confidence interval, 0.70-1.01; P=0.06).

23 and the PSFEARL DS was 0.82 (95% confidence interval, 0.73-0.91) for i-PET and 0.89 (95% confidence

24 benefit (hazard ratio, 0.82; 95% confidence interval, 0.75-0.90; P<0.001).

25 ne group (hazard ratio, 0.91; 95% confidence interval, 0.78 to 1.06; P<0.001 for noninferiority).

26 .73-0.91) for i-PET and 0.89 (95% confidence interval, 0.81-0.96) for EoT-PET.

27 lodipine (hazard ratio, 0.93; 95% confidence interval, 0.84-1.03; P=0.16) was not associated with a s

28 sinopril (hazard ratio, 1.04; 95% confidence interval, 0.94-1.15; P=0.46) or amlodipine (hazard ratio

29 patients (hazard ratio, 1.06; 95% confidence interval, 0.94-1.19; P=0.34).

30 factors (hazard ratio, 1.14; 95% confidence interval, 0.96-1.35), the association was attenuated.

31 ized mean difference = -0.32 [95% confidence interval, -0.44 to -0.19]).

32 dds of CAD (odds ratio: 0.66; 95% confidence interval: 0.44 to 0.98; p = 0.04).

33 nd VNTR 7 DRD4 (odds ratio: 0.68; confidence interval: 0.47-1.00).

34 etter OS (hazard ratio 0.569, 95% confidence interval: 0.478-0.677, P < 0.001) independent of age (P

35 VNTR 10 SLC6A3 (odds ratio: 0.74; confidence interval: 0.60-0.90), whereas the following variants wer

36 s1947274 LPHN3 (odds ratio: 0.95; confidence interval: 0.71-1.26), rs5661665 LPHN3 (odds ratio: 1.07;

37 by 13% (hazard ratio = 0.87, 95% confidence interval: 0.79, 0.96).

38 decrement of 3.70 IQ points (95% confidence interval: 0.83, 6.56).

39 s5661665 LPHN3 (odds ratio: 1.07; confidence interval: 0.84-1.37) and VNTR 7 DRD4 (odds ratio: 0.68;

40 age 7-14 years (beta = -0.01, 95% confidence interval: -0.04, 0.01) and school attendance/home enviro

41 joint mediators beta = -0.07, 95% confidence interval: -0.12, -0.02) than the indirect effects mediat

42 ; n = 5,292; 30%) had a 2.2% (95% confidence interval: -0.3% to 4.6%) absolute risk reduction.

43 rotein B (change in SD units [95% confidence interval]: -0.98 [-1.11, -0.86]) with similar effect mag

44 MT failure (odds ratio, 0.15; 95% confidence interval, .007-.40).

45 ndergoing CPM (BCSS: HR 1.08, 95% confidence interval 1.01-1.16; OS: HR 1.08, 95% confidence interval

46 erval 1.01-1.16; OS: HR 1.08, 95% confidence interval 1.03-1.14), regardless of HR status or age.

47 ascular AMD (odds ratio 1.55 [95% confidence interval 1.31-1.84], P = 2.67 x 10(-7)).

48 zard ratios 0-14 years: 1.51 [95% confidence intervals 1.19 to 1.90]; 15-24 years: 1.37 [1.18 to 1.59

49 ean (prevalence ratio = 1.31 [95% confidence interval = 1.05-1.63] per kJ/m(2)) and minimum (1.25 [1.

50 s of SCC (hazard ratio = 2.3; 95% confidence interval = 1.5-3.6).

51 technique (odds ratio, 1.08; 95% confidence interval, 1.05-1.10; P<0.001).

52 ume of BAV (odds ratio, 1.58; 95% confidence interval, 1.06-2.37; P=0.03).

53 P = 0.003; odds ratio, 1.254; 95% confidence interval, 1.078-1.457).

54 tenuated (hazard ratio, 1.16; 95% confidence interval, 1.08-1.25; P<0.001).

55 baseline (hazard ratio, 1.51; 95% confidence interval, 1.08-2.10) after adjusting for confounders.

56 (adjusted relative risk, 1.6; 95% confidence interval, 1.1-2.5; P=0.02).

57 tional risk (odds ratio, 6.0; 95% confidence interval, 1.1-31.7; P=0.03).

58 d with STDR (odds ratio, 2.3; 95% confidence interval, 1.1-4.9; P = 0.04).

59 udden death (odds ratio, 3.2; 95% confidence interval, 1.1-9.4) were independently associated with th

60 factors (hazard ratio, 1.69; 95% confidence interval, 1.10-2.61; P = 0.018).

61 (adjusted hazard ratio, 1.34; 95% confidence interval, 1.11-1.60; P=0.002) and death (hazard ratio, 2

62 t failure 3.59 times as high (95% confidence interval, 1.12 to 15.94) as that of patients with amount

63 ociated with LBW (aRR = 1.74; 95% confidence interval, 1.18, 2.58; P < .01).

64 (adjusted relative risk, 1.7; 95% confidence interval, 1.2-2.6; P=0.007) and survival with favorable

65 tio for publication was 1.79 (95% confidence interval, 1.20-2.67) in favor of licensed drugs.

66 In 3% of cases (95% confidence interval, 1.3%-6.7%), there was clinically meaningful di

67 igher than expected (SHR=1.4, 95% confidence interval, 1.3-1.4).

68 incidence of 1.8 per 100 000 (95% confidence interval, 1.3-2.2) between 1990 and 2014.

69 odds of cardioembolic stroke (95% confidence interval, 1.39-4.58; P=2.7x10(-3)).

70 agulopathy (odds ratio, 2.19; 95% confidence interval, 1.51-3.18; P<0.001), and low institutional vol

71 t-to-duct) (odds ratio, 3.06; 95% confidence interval, 1.52-6.16; P = 0.002).

72 ticles/ml higher carbon load (95% confidence interval, 1.56 x 10(5) to 9.10 x 10(5) particles/ml) for

73 acks versus whites were 2.61 (95% confidence interval, 1.57-4.34) and 1.79 (1.06-3.03), respectively,

74 ior syncope (odds ratio, 4.0; 95% confidence interval, 1.6-9.7) and a family history of sudden death

75 nd death (hazard ratio, 2.10; 95% confidence interval, 1.60-2.75; P<0.001) increased in the surviving

76 (adjusted hazard ratio, 2.3; 95% confidence interval, 1.7-3.0; P < 0.001).

77 howed a hazard ratio of 2.25 (95% confidence interval, 1.70-2.99) after adjusting for other risk fact

78 ) and COPD (odds ratio, 5.76; 95% confidence interval, 1.9-17.4), but not asthma alone.

79 djusted relative risk = 1.09, 95% confidence interval: 1.04, 1.14; P for trend < 0.001) were associat

80 4680 COMT (odds ratio (OR): 1.40; confidence interval: 1.04-1.87), rs5569 SLC6A2 (odds ratio: 1.73; c

81 djusted relative risk = 1.10, 95% confidence interval: 1.06, 1.15; P for trend < 0.001) and acetamino

82 1800544 ADRA2A (odds ratio: 1.69; confidence interval: 1.12-2.55), rs4680 COMT (odds ratio (OR): 1.40

83 (VNTR) 4 DRD4 (odds ratio: 1.66; confidence interval: 1.16-2.37) and VNTR 10 SLC6A3 (odds ratio: 0.7

84 d endpoint (odds ratio: 2.73; 95% confidence interval: 1.2 to 5.9; p = 0.01).

85 disease (hazard ratio = 1.4, 95% confidence interval: 1.2, 1.6), compared with men with a concentrat

86 rs5569 SLC6A2 (odds ratio: 1.73; confidence interval: 1.26-2.37) and rs28386840 SLC6A2 (odds ratio:

87 izations (hazard ratio = 1.5, 95% confidence interval: 1.4, 1.6) and cardiovascular disease (hazard r

88 8386840 SLC6A2 (odds ratio: 2.93; confidence interval: 1.76-4.90), and, repeat variants variable numb

89 lesterol (change in SD units [95% confidence interval]: -1.01 [-1.14, -0.88]), remnant cholesterol (c

90 lesterol (change in SD units [95% confidence interval]: -1.03 [-1.17, -0.89]), and apolipoprotein B (

91 nterval, 42% to 67%] and 14% [95% confidence interval, 11% to 18%] higher hospitalization rates, resp

92 veness ratios were pound22 201 (95% credible interval 12 662-132 452) per quality-adjusted life-year

93 tor of OD (odds ratio = 14.8; 95% confidence interval: 12.7-17.2).

94 al, 17 411 to 32 788) and 27 413 (prediction interval, 15 188 to 37 734) excess acquisitions, respect

95 166, respectively [P = .241]; 95% confidence interval: -15.1, 60.0), including those from subanalyses

96 0.76; risk difference, 3.1%; 95% confidence interval, -16.2 to 10.1).

97 shootings, there were 25 705 (95% prediction interval, 17 411 to 32 788) and 27 413 (prediction inter

98 PH) to undergo a second MR examination (mean interval, 17 months +/- 4 [standard deviation]) to asses

99 e serum HBsAg, of 2.9% (upper 95% confidence interval, 19%).

100 ng AF was 21.99 times higher (95% confidence interval, 19.26-25.12) in patients with CHD than control

101 (adjusted hazard ratio, 6.26; 95% confidence interval, 2.02-19.41; P=0.0015).

102 ry composite outcome of 3.52 (95% confidence interval, 2.17 to 5.71).

103 ist device (odds ratio, 3.48; 95% confidence interval, 2.25-5.36; P<0.001), coagulopathy (odds ratio,

104 referred beta-lactam therapy (95% confidence interval, 2.4-8.2; P < .0001).

105 caid managed care plans (N = 390) during the interval 2006-2014.

106 interval: 6.9, 50.0) and 46.8% (95% credible interval: 23.2, 64.1).

107 ution to xylem water) is 37% (95% confidence interval, 28-46%).

108 related survival was 37.7 months (confidence interval 29-46 mo).

109 adjusted hazard ratio, 15.63; 95% confidence interval, 4.01-60.89; P<0.0001) and >7 beats (adjusted h

110 enic shock (odds ratio, 6.01; 95% confidence interval, 4.19-8.61; P<0.001), need for left ventricular

111 with ACOS (odds ratio, 16.3; 95% confidence interval, 4.7-55.9) and COPD (odds ratio, 5.76; 95% conf

112 r the OAC alone group: 67.1% (95% confidence interval, 40.9%-83.6%) versus 94.1% (95% confidence inte

113 ears and >/=75 years had 54% [95% confidence interval, 42% to 67%] and 14% [95% confidence interval,

114 le ablation procedure of 54% (95% confidence interval, 43%-68%) in the PVI-only and 57% (95% confiden

115 68%) in the PVI-only and 57% (95% confidence interval, 46%-72%) in the Substrate-modification group (

116 survival (OS) was 30 months (95% confidence interval, 6-54) from start of midostaurin.

117 stimates of the PEF were 28.0% (95% credible interval: 6.9, 50.0) and 46.8% (95% credible interval: 2

118 l, 40.9%-83.6%) versus 94.1% (95% confidence interval, 65%-99.1%) for the OAC plus intravitreous chem

119 ed by 98% of patients (51/52; 95% confidence interval, 90%-100%).

120 accuracy (97%, 34 of 35 eyes, 95% confidence interval 92%-100%) for classifying an eye as PE or PPE.

121 f thyroid hormone levels with 95% confidence intervals (95% CI) obtained from the studies were pooled

122 e, we found y = 0.73x - 1.55 (95% confidence interval [95% CI] slope, 0.71-0.76), giving the conversi

123 zard ratio for DDKF was 2.47 (95% confidence interval [95% CI], 1.21-5.05).

124 5 ka, are surprisingly high for this glacial interval, and remain unexplained by previous models of i

125 ow, because intraplate earthquake recurrence intervals are generally long (10s to 100s of thousands o

126 In staggered 3-month intervals, ASP teams at 3 hospitals received training by

127 with 2-minute and 5-minute riboflavin dosing intervals at 6 months (0.97 and 0.76 diopters, respectiv

128 on, conduction delay, or activation recovery intervals at all sites with ajmaline.

129 efore, the endogenization occurred in a time interval between 20 and 45 million years ago.

130 rd from the South Atlantic Ocean spanning an interval between 30.1 My and 17.1 My ago.

131 to optimize the immunization regimen (dose, interval between doses, and drug partner), this vaccine

132 icodynamic recovery was slow relative to the interval between exposures.

133 The mean time interval between surgical excision of OSSN and onset of

134 Despite the 1-hour warning interval between the earthquake and tsunami, many coasta

135 ff to categorize participants within the FIT interval cancer category.

136 (CRC) by the guaiac fecal occult blood test, interval cancers develop in 48% to 55% of the subjects.

137 or characteristics of screening-detected and interval cancers differ for two-dimensional digital mamm

138 tions, we show that a sea level fall in this interval caused enhanced pressure-release melting in the

139 Using interval-censored survival and binomial regression appro

140 r time [odds ratio (OR) 1.73; 95% confidence interval (CI) 1.03-2.91; P = 0.03].

141 non-Hispanic White (OR 1.10, 95% confidence interval (CI) 1.05-1.16), and care at a National Cancer

142 ay POM [odds ratio (OR) 1.71; 95% confidence interval (CI) 1.05-2.77); P = 0.032], whereas performing

143 sion: hazard ratio (HR) 1.19, 95% confidence interval (CI) 1.09-1.30; (+)sepsis: HR 1.84, 95% CI 1.44

144 basal-like subtype [OR 4.17; 95% confidence interval (CI) 1.89-9.21] compared with both nulliparity

145 naive) had 9.2% higher costs [95% confidence interval (CI) 2.8%-15.6%; adjusted means $26,604 vs $24,

146 quired the lower limit of the 95% confidence interval (CI) of the differences in CRs not exceed 7 per

147 (ORs) or beta-estimates with 95% confidence interval (CI).

148 estimate risk ratio (RR) with 95% confidence interval (CI).

149 ed in hazard ratios (HR) with 95% confidence interval (CI).

150 1st), odds ratio (OR) = 0.66, 95% confidence interval (CI): 0.45, 0.98; P for trend = 0.05).

151 ntile hazard ratio (HR)=1.03 [95% confidence interval (CI): 0.86, 1.25]; third quintile HR=1.14 (95%

152 ed relative risk (RR) = 0.99, 95% confidence interval (CI): 0.90, 1.09), skin tanning ability (for da

153 sits for GI illness was 1.09 [95% confidence interval (CI): 1.03, 1.16] in the 10-14 d period followi

154 ted hazard ratio (HR) = 1.19, 95% confidence interval (CI): 1.03, 1.38).

155 oled odds ratio (pOR) = 1.32, 95% confidence interval (CI): 1.10, 1.58).

156 ence rate ratio (IRR) = 1.86, 95% confidence interval (CI): 1.27, 2.71; for infected wounds, IRR = 3.

157 gers (N = 789) reported 3.79 (95% confidence interval (CI): 1.39-6.19) minutes more daily MVPA than o

158 tile, odds ratio (OR) = 2.70, 95% confidence interval (CI): 1.55, 4.70) and current smokers (OR = 1.9

159 tion attack rates were 78.0% (95% confidence interval (CI): 63.5-86.3%) in French Polynesia which clo

160 illion in the 2006-2007 season (95% credible interval (CI): 8.7, 10.9) to 37.2 million (95% CI: 34.1,

161 gistries (sensitivity of 89%, 95% confidence interval (CI): 86, 92).

162 ion; the incidence rates with 95% confidence intervals (CI) per 1,000 person-years were as follows: n

163 and hazard ratios (HRs), with 95% confidence intervals (CI), for the time-dependent risk related to E

164 10 (adjusted risk ratio 0.44, 95% confidence interval [CI] 0.26-0.75).

165 adults (odds ratio [OR] 0.50 95% confidence interval [CI] 0.31-0.79, P = 0.003), schoolchildren (but

166 of 15.8 percentage points; 97.5% confidence interval [CI] 0.5-31.2; P = .021).

167 limate (Odds Ratio [OR]=2.76, 95% Confidence Interval [CI] 1.51-5.03), people-oriented culture (OR=2.

168 aria within 1 year was 33.8% (95% confidence Interval [CI] 33.1%-34.5%) after initial monoinfection w

169 CT (32% decrease in DTN time, 95% confidence interval [CI] 38%-55%), stretcher to CT (30% decrease in

170 Overall SVR rates were 89.8% (95% confidence interval [CI] 89.2-90.4) in white, 89.8% (95% CI 89.0-90

171 ted hazard ratio [HR] = 5.14; 95% confidence interval [CI] = 1.77-14.92; P = .003).

172 rates, 0.7 percentage points; 95% confidence interval [CI], -1.5 to 2.8; P=0.007 for noninferiority;

173 ging-derived AAR (bias, 0.18; 95% confidence interval [CI], -1.6 to 1.3) and AAR derived from native

174 26%) had worse 6MWD = -109 m (95% confidence interval [CI], -175 to -43), London Chest Activity of Da

175 etween-group difference, 0.0; 95% confidence interval [CI], -2.0 to 2.1) or the Tiredness score (3.2+

176 (1-year change in LVEF -3.6%; 95% confidence interval [CI], -4.4% to -2.8%; 3-year change -3.8%; 95%

177 ncy, -22.8 percentage points; 95% confidence interval [CI], -41.1 to -5.4; P=0.01).

178 e surgery group was -45.0 kg (95% confidence interval [CI], -47.2 to -42.9; mean percent change, -35.

179 ted to have ranged from 0.3% (95% confidence interval [CI], .1%-1.9%; 1 of 284 participants) to 1% (9

180 men (hazard ratio [HR], 0.43; 95% confidence interval [CI], .33-.57) and attainment of sustained viro

181 lia almost halved (IRR, 0.53; 95% confidence interval [CI], .50-.57), but differed by PCV era.

182 tive effectiveness was 24.0% (95% confidence interval [CI], .6%-42%); there was evidence of variation

183 ted odds ratios [aOR] = 0.21; 95% confidence interval [CI], 0.05 to 0.97), 50-64 years (aOR = 0.48; 9

184 on (relative risk [RR], 0.32; 95% confidence interval [CI], 0.06-1.85; I(2) = 0%) and of waitlist dro

185 VA improvement of 0.17 units, 95% confidence interval [CI], 0.12-0.20, P < 0.01), whereas those who w

186 hazard ratio (HR) was 0.543 (95% confidence interval [CI], 0.321-0.918; P = .021), with median PFS o

187 ol group (relative risk, 1.6; 95% confidence interval [CI], 0.4 to 6.8; absolute difference in risk,

188 citation (hazard ratio, 0.62; 95% confidence interval [CI], 0.47 to 0.82), as well as a lower risk of

189 nib (hazard ratio [HR], 0.66; 95% confidence interval [CI], 0.57-0.77), being seen at a National Canc

190 reas under the curve of 0.72 (95% confidence interval [CI], 0.65 to 0.79) for the SPIROMICS cohort an

191 PAD (hazard ratio [HR] 0.79; 95% confidence interval [CI], 0.66-0.94; P=0.0098) and without PAD (HR

192 [11.3%]; hazard ratio, 0.85; 95% confidence interval [CI], 0.79 to 0.92; P<0.001) and the key second

193 bo group (hazard ratio, 0.91; 95% confidence interval [CI], 0.83 to 1.00), with the intention-to-trea

194 y (odds ratio, 1.04 per hour; 95% confidence interval [CI], 1.02 to 1.05; P<0.001), as was a longer t

195 (prevalence ratio [PR], 1.05; 95% confidence interval [CI], 1.03-1.07).

196 [HR], 1.10 per 10% increase; 95% confidence interval [CI], 1.04-1.16), low CSF to blood glucose rati

197 umulative incidence was 2.3% (95% confidence interval [CI], 1.1-3.4), 3.5% (95% CI, 2.1-5.0), and 4.4

198 n age (odds ratio [OR], 1.44; 95% confidence interval [CI], 1.20-1.72; P < 0.01).

199 cts (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.22-1.37) and metabolically unhealthy ob

200 ed hazard ration [aHR], 1.55, 95% confidence interval [CI], 1.34-1.8) and medium (aHR, 1.24; 95% CI,

201 s as great as in noncarriers (95% confidence interval [CI], 1.4 to 2.7).

202 e from baseline [GMFR] = 1.6 [95% confidence interval [CI], 1.4,1.7], P value < .0001) and IFN-gamma

203 dized mean differences, 2.07; 95% confidence interval [CI], 1.44 to 2.69), but not minutes per week o

204 V RNA detection were 14 days (95% confidence interval [CI], 11 to 17) and 54 days (95% CI, 43 to 64),

205 ere were 646 patients (11.9%; 95% confidence interval [CI], 11.1%-12.8%) with 727 distinct HAIs, of w

206 thly influenza cases was 19.3% (95% credible interval [CI], 14.7%-23.4%), 16.3% (95% CI, 13.6%-19.0%)

207 lonization worldwide was 18% (95% confidence interval [CI], 17%-19%), with regional variation (11%-35

208 DNA was identified in 25.7% (95% confidence interval [CI], 17.8%-33.7%) of newborns studied.

209 ed with systolic (4.58 mm Hg; 95% confidence interval [CI], 2.64-6.51) and diastolic (2.25 mm Hg; 95%

210 creased risk of RD was 12.42 (95% confidence interval [CI], 2.91-53.01; P = 0.001) for eyes of childr

211 ncidence of 22.6 per 100 PYO (95% confidence interval [CI], 20.4-25.0).

212 hema migrans ranged from 36% (95% confidence interval [CI], 25%-50%) to 54% (95% CI, 42%-67%), compar

213 against A(H1N1)pdm09 was 43% (95% confidence interval [CI], 25%-57%).

214 We estimated that 14.1% (95% confidence interval [CI], 6.3-21.9%) of HPV DNA detections in genit

215 he index MI admission, 66.8% (95% confidence interval [CI], 65.9-67.8) had EF reassessment within the

216 low-up (implant: 11.9 points; 95% confidence interval [CI], 8.6-15.2; P < 0.001; systemic: 9.0 points

217 diagnostic accuracy of 94.8% (95% confidence interval [CI], 89.4 to 97.6), a sensitivity of 94.7% (95

218 ve predictive value of 96.0% (95% confidence interval [CI], 90.2% to 98.9%), 65.9% (95% CI, 59.0% to

219 ement was excellent at 99.0% (95% confidence interval [CI], 98.6% to 99.2%; kappa, 0.89), with the Lu

220 (weighted prevalence = 0.03%; 95% confidence interval [CI]: 0.01% to 0.04%) compared with interarteri

221 MI (hazard ratio [HR]: 0.65; 95% confidence interval [CI]: 0.50 to 0.84; p = 0.001), although there

222 GFR (hazard ratio [HR]: 0.77; 95% confidence interval [CI]: 0.66 to 0.89; p < 0.001), doubling of ser

223 ar 1 hazard ratio [HR]: 0.82; 95% confidence interval [CI]: 0.67 to 0.99; year 2 HR: 0.90; 95% CI: 0.

224 a ranging from 1.25 for PFOS (95% Confidence Interval [CI]: 0.90, 1.72) to 4.01 for PFDA (95% CI: 1.4

225 jects (odds ratio [OR]: 1.75, 95% confidence interval [CI]: 1.08-2.83, P-value<0.05).

226 of averaged risk [RAR]: 3.2; 95% confidence interval [CI]: 1.5 to 7.5), LMWH and VKA (16%; RAR: 3.1;

227 General obesity (OR = 5.94, 95% confidence interval [CI]: 3.69-9.55) and central obesity (OR = 3.45

228 ntion (rate ratio [RR], 0.05 [95% confidence interval {CI}, .01-.38]).

229 dictive of reduced SVR (0.51 [95% confidence interval {CI}, .31-.87]; P = .01).

230 ficantly for SSTI (aOR, 0.85 [95% confidence interval {CI}, .76-.95]) and respiratory infection (aOR,

231 (overall weighted AF, 40.3% [95% confidence interval {CI}, 37.6%-44.3%]), though the AF was substant

232 experience (difference, 20.0; 95% confidence interval, CI, 16.6-23.3).

233 ality rate ratios (MRRs) with 95% confidence intervals (CIs) for all-cause and liver-related mortalit

234 ulate hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer-specific mortality by low-dos

235 te-adjusted hazard ratios and 95% confidence intervals (CIs) for FI risk in women receiving MHT, adju

236 o estimate relative risks and 95% confidence intervals (CIs) from Cox proportional hazards models adj

237 cally significant difference; 95% confidence intervals (CIs) were calculated.

238 djusted odds ratios (ORs) and 95% confidence intervals (CIs).

239 The genetic architecture of the PR interval comprises modulators of atrial fibrillation ris

240 ABE) acceptance criteria of a 90% confidence interval contained within the confidence limits of 80.00

241 The probability of interval CRC by the end of follow-up was 7.1% in black p

242 ental, although a causal link explaining the interval delay between maternal symptoms and observed fe

243 specific to behavioral choice, scalable with interval duration, and doesn't reflect reward prediction

244 liver biochemistry were performed at regular intervals during follow-up.

245 ovide methodology for hypothesis testing and interval estimation.

246 The optimal time interval for re-resection for both patient selection and

247 The optimal time interval for re-resection for incidentally discovered ga

248 The 95% confidence interval for RMS diameters is 5.48 +/- 1.76 mum-signific

249 0.53); the upper limit of the 95% confidence interval for the difference in event rates fell within t

250 0.76 diopters, respectively; 90% confidence interval for treatment difference, -0.23 to 0.66; per-pr

251 were measured at baseline and at 5-15-minute intervals for 4 hours after infusion of study drug.

252 e, melanoma hazard ratios and 95% confidence intervals for lithium exposure were estimated using Cox

253 this study, we sought to validate PGS for QT interval in 2 real-world cohorts of European ancestry (E

254 tiation of anticipatory licking for the next interval in a frequency-dependent manner.

255 ms; I-wave protocol) or at an interstimulus interval in-between I-waves (3.5 ms; control protocol) o

256 and by extensive widening of hypomethylated intervals in ancestral species.

257 rosclerotic burden (increase [95% confidence interval] in rank of plaque volume for each 10-year incr

258 ith recommendation for a 3-year surveillance interval included family history of colorectal cancer an

259 presymptomatic reduction or absence of short interval intracortical inhibition, accompanied by increa

260 -year surveillance intervals (unless shorter interval is indicated by individual findings), and a CF-

261 referred to here as an inter-test reactivity interval (ITRI).

262 ral activations revealed that different time intervals jointly encode the acoustic similarity of both

263 he deposition of the organic-rich (sapropel) interval known as S5.

264 tion of the motor cortex at an interstimulus interval mimicking the rhythmicity of descending late in

265 merge first from marrow, after a postmitotic interval of 1.6 d, and circulate for a day.

266 nephrostogram results, with a 95% confidence interval of 69.2% and 100%.

267 ecords rapid degassing of CO2, suggesting an interval of anomalous fluid source.

268 he use of a dosing strategy that provides an interval of no or low nitrate exposure during each 24-h

269 a loss less than first-percentile confidence interval of the variability in this group.

270 rovided prevalence ratios and 95% confidence intervals of ERG expression in relation to patient chara

271 motif length and calculating the confidence intervals of estimated parameters.

272 term variations in the earthquake recurrence intervals of intraplate faults therefore are poorly unde

273 lative to the first response, whereas longer intervals of quiescence induce an enhanced second respon

274 For shorter intervals of signaling quiescence, the second response i

275 in coding genes: 23.5%-59.3% (95% confidence interval) of highly expressed genes with distant alterna

276 ition characterized by abnormally 'short' QT intervals on the ECG and increased susceptibility to car

277 At regular intervals over 180 min, appetite (visual analog scales),

278 this work include Martens Uncertainty test, interval Partial Least Square Regression (iPLS) and Gene

279 -O variability and particularly with stadial intervals, remains poorly constrained by paleoclimate re

280 The SUVR time interval resulting in the highest correlation and slope

281 we also show that a change to the CS-US time interval results in long-term changes in cortico-striata

282 s predicted the classification of sub-second intervals (steeper dilation = "Longer" classifications).

283 nce of excessive fluids, and regular voiding intervals that reduce urgency incontinence episodes.

284 After 4 doses at weekly intervals, the survival period of the mice extended beyo

285 to competing causes of death over this dose interval.These results confirm and extend earlier findin

286 Moreover, the intervals they mapped to harbored few metabolism-associa

287 ) guided TSMB at appropriate 20 to 40-minute intervals throughout each case.

288 Finally, interval timing and striatal ramping activity are disrup

289 re consistent with drift-diffusion models of interval timing.

290 z) in the medial frontal cortex (MFC) during interval timing.

291 We estimated that 239 000 (95% uncertainty interval [UI] 194 000-298 000) children younger than 15

292 of today's children (57.3%; 95% uncertainly interval [UI], 55.2 to 60.0) will be obese at the age of

293 5-year re-screening and 3-year surveillance intervals (unless shorter interval is indicated by indiv

294 stimated by hazard ratios and 95% confidence intervals using Cox models adjusted for confounders.

295 /kg belatacept every 2 weeks, and the dosing interval was extended to 4 weeks after 5 applications.

296 ificantly greater than 0, but the confidence interval was predominantly positive (M=0.019; CL95 -0.00

297 Within this interval, we identified disruptive mutations in two gene

298 r survival; hazard ratios and 95% confidence intervals were 1.63 (1.27-2.08), 1.38 (1.11-1.72), and 0

299 mpared with the standard arm (95% confidence intervals) were 1.18 (0.40 to 3.33), 1.61 (0.87 to 2.97)

300 cal bulk insulator breaks for specific field intervals within the plateaus.